AFT Pharmaceuticals Ltd

What is AFT Pharmaceuticals Ltd about?
AFT Pharmaceuticals (ASX:AFP) is a growing multinational pharmaceutical company that develops, markets, and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories. AFT's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs. AFT Pharmaceuticals' operations are focused on the development, commercialisation, and distribution of its pharmaceutical products. The company has a team of experienced and knowledgeable staff who are able to work with healthcare professionals to ensure that patients have access to the medicines they need. AFT Pharmaceuticals' current projects include the development of new pharmaceutical products, the expansion of its international footprint, and the acquisition of new products and businesses. The company is also working on a number of initiatives to improve its manufacturing and supply chain capabilities.
AFT Pharmaceuticals Ltd company media
Company Snapshot
ownership
Ownership
Public
employees
Employees
101
sector
Sector
Health Care
headOffice
Head Office
Auckland, New Zealand
yearFounded
Year Founded
1997
What does AFT Pharmaceuticals Ltd specialise in?
/Pharmaceutical /Biotech /Healthcare /Health /Medical /Manufacturing
Icon representing a globe with map pin
Where does AFT Pharmaceuticals Ltd operate? Locations of AFT Pharmaceuticals Ltd global operations

Locations

  • Map pin icon
    Global view
  • Map pin icon
    New Zealand
  • Map pin icon
    Australia
  • Map pin icon
    United Kingdom
  • Map pin icon
    Singapore
  • Map pin icon
    Hong Kong
  • Map pin icon
    Malaysia
Global operations world map
Leaflet
What are AFT Pharmaceuticals Ltd’s services?
Overview of AFT Pharmaceuticals Ltd offerings
Over-the-counter (OTC) medicines: AFT Pharmaceuticals develops, licences, and sells a range of OTC medicines, including pain relievers, cold and flu treatments, and allergy medications.
Prescription medicines: AFT Pharmaceuticals also develops, licences, and sells prescription medicines, such as treatments for chronic pain and inflammation.
Repurposing of existing drugs: Aft Pharmaceuticals is known for its expertise in repurposing existing drugs for new uses. This means that the company can develop new products more quickly and cheaply than if it was developing new drugs from scratch.
Contract manufacturing: AFT Pharmaceuticals also offers contract manufacturing services to other pharmaceutical companies. This means that the company can manufacture drugs for other companies on a contract basis.
Research and development: AFT Pharmaceuticals has a strong research and development pipeline, with a number of new products in development. The company's focus is on developing new and innovative treatments for pain, inflammation, and other conditions.
Licensing of intellectual property: AFT Pharmaceuticals licences its intellectual property to other pharmaceutical companies. This means that other companies can use Aft Pharmaceuticals' technologies to develop their own products.
Who is in the AFT Pharmaceuticals Ltd executive team?
AFT Pharmaceuticals Ltd leadership team
  • Dr. Hartley Atkinson Ph.D.
    Dr. Hartley Atkinson Ph.D.
    Co-Founder, CEO, MD & Exec. Director
  • Ms. Marree Atkinson
    Ms. Marree Atkinson
    Co-Founder, Chief of Staff & Exec. Director
  • Mr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ
    Mr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ
    CFO & Company Sec.
  • Mr. Murray Keith
    Mr. Murray Keith
    Group Marketing Mang.
  • Ms. Ioana Stanescu
    Ms. Ioana Stanescu
    Head of Drug Devel.
  • Mr. Calvin Mackenzie
    Mr. Calvin Mackenzie
    Gen. Mang. of AFT Australia
  • Mr. Scott Crawford
    Mr. Scott Crawford
    Gen. Mang. of Promoted Products Australasia & South East Asia
  • Ms. Louise Clayton
    Ms. Louise Clayton
    Director of International Bus.